Get started
Author

Mourad Lahfa

Definition of treatment goals for moderate to severe psoriasis: a European consensus
2010 · U. Mrowietz, K. Kragballe, et al. · Archives of Dermatological Research · 923
PDF
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
2005 · K.A. Papp, S. Tyring, et al. · British Journal of Dermatology · 689
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
2008 · T. Ruzicka, C.W. Lynde, et al. · British Journal of Dermatology · 412
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
2002 · Sakari Reitamo, Malcolm Rustin, et al. · Journal of Allergy and Clinical Immunology · 255
Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension
2008 · P.C.M. van de Kerkhof, S. Segaert, et al. · British Journal of Dermatology · 180
Long‐term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis
2004 · TA Luger, M Lahfa, et al. · Journal of Dermatological Treatment · 119
A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity
2006 · N. Poulalhon, E. Begon, et al. · British Journal of Dermatology · 88
Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis
2014 · C. Phan, M.‐L. Sigal, et al. · Journal of the European Academy of Dermatology and Venereology · 73
Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies
2014 · J.‐M. Carrascosa, M.B.A. van Doorn, et al. · Journal of the European Academy of Dermatology and Venereology · 56
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial
2005 · A.B. Gottlieb, C.E.M. Griffiths, et al. · British Journal of Dermatology · 55
Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities
2013 · E. Mahé, F. Maccari, et al. · British Journal of Dermatology · 53
Superiority of tacrolimus 0·1% ointment compared with fluticasone 0·005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial
2009 · N. Doss, S. Reitamo, et al. · British Journal of Dermatology · 48
Significant delay in the introduction of systemic treatment of moderate to severe psoriasis: a prospective multicentre observational study in outpatients from hospital dermatology departments in France
2012 · A. Maza, M.A. Richard, et al. · British Journal of Dermatology · 36
Efficacy of Ustekinumab in Palmoplantar Psoriasis
2010 · C. Bulai Livideanu, M. Lahfa, et al. · Dermatology · 33
Efficacy, Safety and Tolerability of an Optimized Avulsion Technique with Onyster® (40% Urea Ointment with Plastic Dressing) Ointment Compared to Bifonazole-Urea Ointment for Removal of the Clinically Infected Nail in Toenail Onychomycosis: a Randomized Evaluator-Blinded Controlled Study
2013 · M. Lahfa, C. Bulai-Livideanu, et al. · Dermatology · 29
Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis
2011 · C. Pouplard, P.-A. Gourraud, et al. · British Journal of Dermatology · 26
A Multicenter, Randomized, Open-Label, Controlled Study Comparing the Efficacy, Safety and Cost-Effectiveness of a Sequential Therapy with RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-Forming Solution with Amorolfine Nail Lacquer Alone in Dermatophytic Onychomycosis
2013 · C. Paul, D. Coustou, et al. · Dermatology · 18
The impact of psoriasis on professional life: Pso PRO , a French national survey
2018 · P. Claudepierre, M. Lahfa, et al. · Journal of the European Academy of Dermatology and Venereology · 11
Élaboration d’un référentiel d’éducation thérapeutique dans le psoriasis
2011 · S. Balica, C. Bernier, et al. · Annales de Dermatologie et de Vénéréologie · 8
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients
2021 · Roland Aschoff, Anthony Bewley, et al. · Dermatology and Therapy · 7
PDF
Incidence and risk factors for treatment failure with infliximab in psoriasis
2013 · H. Escande, C. Bulai Livideanu, et al. · Journal of the European Academy of Dermatology and Venereology · 7
Rhumatisme psoriasique en France, du nourrisson à la personne âgée : données de deux études transversales multicentriques
2017 · A. Galezowski, F. Maccari, et al. · Annales de Dermatologie et de Vénéréologie · 6
Iatrogenic adrenal insufficiency associated with calcipotriol–betamethasone topical combination in psoriasis
2010 · M. Giannitelli, A. Maza, et al. · Clinical and Experimental Dermatology · 6
Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real‐life practice: The Resoswitch study
2018 · Fadia Dabouz, Abdallah Khemis, et al. · Dermatologic Therapy · 3
Prise en charge de l’eczéma chronique des mains
2014 · M. Lahfa · Annales de Dermatologie et de Vénéréologie · 3
Works count: 63
Citation count: 3,147
H-index: 17
I10-index: 18
Year
Topic
Type